-transparent.png){kind=logo}
Lung volume reduction surgery (LVRS) has been demonstrated to improve lung function, exercise tolerance and quality of life. However, the duration of improvement is unknown. While the maximal duration of improvement cannot be determined at this time due to an inadequate period of follow-up, we have observed in some patients significant and relatively rapid declines in gains following LVRS. We describe 6 patients who increased FEV1 by at least 10% of the predicted value after LVRS and subsequently experienced rapid loss of the increment in FEV1 (mean loss 79%, 95% CI 58-100%) over a period ranging from 14 to 20 months following surgery.
Related Publications
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
December 2000,
Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia,
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
February 1999,
American journal of respiratory and critical care medicine,
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
January 2005,
American journal of respiratory and critical care medicine,
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
January 1998,
Lung,
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
September 1999,
The Japanese journal of thoracic and cardiovascular surgery : official publication of the Japanese Association for Thoracic Surgery = Nihon Kyobu Geka Gakkai zasshi,
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
December 1999,
Chest,
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
June 2001,
American journal of respiratory and critical care medicine,
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
May 2008,
Proceedings of the American Thoracic Society,
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
June 2021,
The Annals of thoracic surgery,
S Kesten, and
E Elpern, and
W Warren, and
P Szidon
August 2014,
Medical archives (Sarajevo, Bosnia and Herzegovina),
